Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3781766 | 0.78 | LPL (0.30) | — | |
| SCHEMBL5047339 | 0.72 | MAPT (0.32) | — | |
| SCHEMBL3787769 | 0.72 | ALDH1A1 (0.31) | ALDH1A1POLBMAPK1SMN1; SMN2 | |
| SCHEMBL3781548 | 0.71 | MAPT (0.35) | ALDH1A1 | |
| SCHEMBL27472507 | 0.70 | — | — | |
| SCHEMBL28451804 | 0.70 | ALDH1A1 (0.38) | ALDH1A1POLBMAPK1SMN1; SMN2PRKCZ | |
| SCHEMBL1604907 | 0.68 | ALDH1A1 (0.47) | ALDH1A1POLBMAPK1SMN1; SMN2PRKCZ | |
| SCHEMBL22193213 | 0.68 | ALDH1A1 (0.47) | ALDH1A1POLBMAPK1SMN1; SMN2PRKCZ | |
| SCHEMBL3789254 | 0.65 | MAPT (0.34) | — | |
| SCHEMBL3790986 | 0.65 | LPL (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2010-04-08 | — | — | US | disclosed |
| EP-1914221-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | NISCH, BLVRB, BBOX1 | ALDH1A1 4339/4885POLB 2303/4885MAPK1 4726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.